A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity
暂无分享,去创建一个
G. Mills | K. Hess | V. Valero | M. Scoggins | B. Adrada | R. Murthy | A. Thompson | H. Piwnica-Worms | E. Mittendorf | B. Arun | G. Whitman | T. Helgason | C. Barcenas | J. Litton | D. Ramirez | S. Moulder | J. Gomez